Multivalent influenza vaccine based on hybrid protein

The vaccine was obtained by genetic engineering

   Vaccine developed by methods of molecular biology, genetic engineering and recombinant DNA. Highly effective vaccine are based on hybrid proteins (do not contain the viruses themselves). Proposed vaccine are characterized by greater efficiency and safety compared to the commercial vaccines, as well as a wider range of applications.

   Provides universal protection against the influenza virus.

   Have no analogues in the world. 

Fill in your application

Please, fill in your application
Do you want to get a specialist consultation?